Goldman Sachs
FBRX icon

Goldman Sachs’s Forte Biosciences FBRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-20,776
Closed -$11.2K 4888
2024
Q2
$11.2K Buy
20,776
+2
+0% +$1 ﹤0.01% 4635
2024
Q1
$14.5K Buy
20,774
+34
+0.2% +$24 ﹤0.01% 4630
2023
Q4
$17K Sell
20,740
-13,016
-39% -$10.7K ﹤0.01% 4618
2023
Q3
$22.3K Buy
33,756
+12,937
+62% +$8.56K ﹤0.01% 4552
2023
Q2
$21.7K Buy
20,819
+197
+1% +$205 ﹤0.01% 4747
2023
Q1
$20.8K Buy
20,622
+289
+1% +$292 ﹤0.01% 4878
2022
Q4
$20.3K Sell
20,333
-50
-0.2% -$50 ﹤0.01% 4891
2022
Q3
$22K Sell
20,383
-12,419
-38% -$13.4K ﹤0.01% 5149
2022
Q2
$43K Buy
32,802
+5,182
+19% +$6.79K ﹤0.01% 5309
2022
Q1
$40K Sell
27,620
-57,620
-68% -$83.4K ﹤0.01% 5504
2021
Q4
$182K Buy
85,240
+72,206
+554% +$154K ﹤0.01% 5033
2021
Q3
$39K Sell
13,034
-24,869
-66% -$74.4K ﹤0.01% 5235
2021
Q2
$1.27M Buy
37,903
+4,835
+15% +$163K ﹤0.01% 3853
2021
Q1
$1.13M Buy
+33,068
New +$1.13M ﹤0.01% 3814
2020
Q1
Sell
-48,947
Closed -$26K 4445
2019
Q4
$26K Buy
48,947
+25,880
+112% +$13.7K ﹤0.01% 4245
2019
Q3
$15K Buy
23,067
+11,970
+108% +$7.78K ﹤0.01% 4197
2019
Q2
$74K Sell
11,097
-47,432
-81% -$316K ﹤0.01% 4047
2019
Q1
$636K Buy
58,529
+11,442
+24% +$124K ﹤0.01% 3460
2018
Q4
$387K Buy
47,087
+24,250
+106% +$199K ﹤0.01% 3508
2018
Q3
$356K Sell
22,837
-2,266
-9% -$35.3K ﹤0.01% 3591
2018
Q2
$235K Buy
25,103
+11,867
+90% +$111K ﹤0.01% 3826
2018
Q1
$157K Buy
13,236
+1,285
+11% +$15.2K ﹤0.01% 3930
2017
Q4
$122K Buy
+11,951
New +$122K ﹤0.01% 3939
2017
Q3
Sell
-30,405
Closed -$366K 4309
2017
Q2
$366K Buy
+30,405
New +$366K ﹤0.01% 3695